Clopidogrel
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Cardiac & Hypertension treatment.
🧴 Clinical Application
Take orally once daily with a glass of water, with or without meals. Maintain consistent daily timing. Do not discontinue without consulting your cardiologist.
⚠️ Side Effects
Common: Hematoma, epistaxis, gastrointestinal hemorrhage, bruising, dyspepsia, diarrhea. Rare/Severe: Boxed warning: Diminished antiplatelet effect in CYP2C19 poor metabolizers; major fatal hemorrhage, and thrombotic thrombocytopenic purpura (TTP).
🛡️ Safety Warnings
Black box warning: Reduced effectiveness in CYP2C19 poor metabolizers; consider alternative P2Y12 inhibitors (prasugrel, ticagrelor) if indicated. Contraindicated in active pathological bleeding (peptic ulcer, intracranial hemorrhage). Avoid concurrent omeprazole/esomeprazole which inhibit CYP2C19; use pantoprazole instead if gastric protection is needed.
Jan Aushadhi Products containing Clopidogrel
Found 12 generic formulation(s) containing this active ingredient.
Clopidogrel Tablets 75mg
Clopidogrel Bisulphate is an oral thienopyridine P2Y12 platelet inhibitor on the WHO Model List of Essential Medicines. It requires hepatic bioactivation by CYP2C19 to form an active thiol metabolite that irreversibly modifies platelet P2Y12 ADP receptors for the entire 7-10 day lifespan of the platelet, preventing ADP-induced platelet activation and fibrinogen binding. Indicated for secondary prevention of atherothrombotic events in patients with recent myocardial infarction, recent ischemic stroke, or established peripheral arterial disease, and as part of DAPT in acute coronary syndromes.
Clopidogrel 75mg + Aspirin 75mg Tablets
Clopidogrel and Aspirin is the cornerstone Dual Antiplatelet Therapy (DAPT) on the WHO Model List of Essential Medicines. Aspirin irreversibly acetylates platelet cyclooxygenase-1 (COX-1), blocking thromboxane A2 production, while clopidogrel is an oral thienopyridine prodrug whose active metabolite irreversibly binds to platelet P2Y12 adenosine diphosphate (ADP) receptors, preventing ADP-mediated glycoprotein IIb/IIIa activation. This dual blockade potently inhibits platelet aggregation across complementary pathways. Indicated for acute coronary syndromes (STEMI, NSTEMI, unstable angina) and prevention of subacute stent thrombosis following percutaneous coronary intervention (PCI).
Atorvastatin 10mg + Clopidogrel 75mg Capsules
Statin and Antiplatelet (Aspirin +/- Clopidogrel) cardiovascular polypill formulation. Unites intensive lipid lowering and plaque stabilization (via HMG-CoA reductase inhibition) with antiplatelet thrombus prevention (via irreversible COX-1 inhibition and/or ADP P2Y12 platelet receptor blockade). Indicated for secondary prevention in coronary artery disease, acute coronary syndrome, post-percutaneous coronary intervention (PCI/stenting), and ischemic stroke.
Rosuvastatin 10mg + Clopidogrel 75mg Capsules
Statin and Antiplatelet (Aspirin +/- Clopidogrel) cardiovascular polypill formulation. Unites intensive lipid lowering and plaque stabilization (via HMG-CoA reductase inhibition) with antiplatelet thrombus prevention (via irreversible COX-1 inhibition and/or ADP P2Y12 platelet receptor blockade). Indicated for secondary prevention in coronary artery disease, acute coronary syndrome, post-percutaneous coronary intervention (PCI/stenting), and ischemic stroke.
Atorvastatin 20mg + Clopidogrel 75mg Capsules
Statin and Antiplatelet (Aspirin +/- Clopidogrel) cardiovascular polypill formulation. Unites intensive lipid lowering and plaque stabilization (via HMG-CoA reductase inhibition) with antiplatelet thrombus prevention (via irreversible COX-1 inhibition and/or ADP P2Y12 platelet receptor blockade). Indicated for secondary prevention in coronary artery disease, acute coronary syndrome, post-percutaneous coronary intervention (PCI/stenting), and ischemic stroke.
Atorvastatin 20mg + Clopidogrel 75mg + Aspirin 75mg Capsules
Statin and Antiplatelet (Aspirin +/- Clopidogrel) cardiovascular polypill formulation. Unites intensive lipid lowering and plaque stabilization (via HMG-CoA reductase inhibition) with antiplatelet thrombus prevention (via irreversible COX-1 inhibition and/or ADP P2Y12 platelet receptor blockade). Indicated for secondary prevention in coronary artery disease, acute coronary syndrome, post-percutaneous coronary intervention (PCI/stenting), and ischemic stroke.
Clopidogrel 75mg + Aspirin 150mg Capsules
Clopidogrel and Aspirin is the cornerstone Dual Antiplatelet Therapy (DAPT) on the WHO Model List of Essential Medicines. Aspirin irreversibly acetylates platelet cyclooxygenase-1 (COX-1), blocking thromboxane A2 production, while clopidogrel is an oral thienopyridine prodrug whose active metabolite irreversibly binds to platelet P2Y12 adenosine diphosphate (ADP) receptors, preventing ADP-mediated glycoprotein IIb/IIIa activation. This dual blockade potently inhibits platelet aggregation across complementary pathways. Indicated for acute coronary syndromes (STEMI, NSTEMI, unstable angina) and prevention of subacute stent thrombosis following percutaneous coronary intervention (PCI).
Rosuvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsules
Statin and Antiplatelet (Aspirin +/- Clopidogrel) cardiovascular polypill formulation. Unites intensive lipid lowering and plaque stabilization (via HMG-CoA reductase inhibition) with antiplatelet thrombus prevention (via irreversible COX-1 inhibition and/or ADP P2Y12 platelet receptor blockade). Indicated for secondary prevention in coronary artery disease, acute coronary syndrome, post-percutaneous coronary intervention (PCI/stenting), and ischemic stroke.
Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg Capsules
Statin and Antiplatelet (Aspirin +/- Clopidogrel) cardiovascular polypill formulation. Unites intensive lipid lowering and plaque stabilization (via HMG-CoA reductase inhibition) with antiplatelet thrombus prevention (via irreversible COX-1 inhibition and/or ADP P2Y12 platelet receptor blockade). Indicated for secondary prevention in coronary artery disease, acute coronary syndrome, post-percutaneous coronary intervention (PCI/stenting), and ischemic stroke.
Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsules
Statin and Antiplatelet (Aspirin +/- Clopidogrel) cardiovascular polypill formulation. Unites intensive lipid lowering and plaque stabilization (via HMG-CoA reductase inhibition) with antiplatelet thrombus prevention (via irreversible COX-1 inhibition and/or ADP P2Y12 platelet receptor blockade). Indicated for secondary prevention in coronary artery disease, acute coronary syndrome, post-percutaneous coronary intervention (PCI/stenting), and ischemic stroke.
Clopidogrel 150mg Tablets
Clopidogrel Bisulphate is an oral thienopyridine P2Y12 platelet inhibitor on the WHO Model List of Essential Medicines. It requires hepatic bioactivation by CYP2C19 to form an active thiol metabolite that irreversibly modifies platelet P2Y12 ADP receptors for the entire 7-10 day lifespan of the platelet, preventing ADP-induced platelet activation and fibrinogen binding. Indicated for secondary prevention of atherothrombotic events in patients with recent myocardial infarction, recent ischemic stroke, or established peripheral arterial disease, and as part of DAPT in acute coronary syndromes.
Rosuvastatin 20Mg + Clopidogrel 75Mg Capsules
Statin and Antiplatelet (Aspirin +/- Clopidogrel) cardiovascular polypill formulation. Unites intensive lipid lowering and plaque stabilization (via HMG-CoA reductase inhibition) with antiplatelet thrombus prevention (via irreversible COX-1 inhibition and/or ADP P2Y12 platelet receptor blockade). Indicated for secondary prevention in coronary artery disease, acute coronary syndrome, post-percutaneous coronary intervention (PCI/stenting), and ischemic stroke.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Clopidogrel.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Clopidogrel Tablets 75mg | 10's | ₹19.28 | CLOPILET, CLOPITAB, CLOPICARD, DEPLATT | ₹63.72 | 70% Save |
| Clopidogrel 75mg + Aspirin 75mg Tablets | 10's | ₹21.66 | DEPLATT, CLOPIVAS, CLOPICARD | ₹60.89 | 64% Save |
| Atorvastatin 10mg + Clopidogrel 75mg Capsules | 10's | ₹39.70 | ATORFIT, CLOPITAB, CLOPITORVA, ATORNIZ, AVAS | ₹171.56 | 77% Save |
| Rosuvastatin 10mg + Clopidogrel 75mg Capsules | 10's | ₹43.32 | NOVASTAT CV, ROSEDAY, ROSUFIT | ₹186.62 | 77% Save |
| Atorvastatin 20mg + Clopidogrel 75mg Capsules | 10's | ₹39.70 | ATORFIT, CLOPITAB | ₹314.88 | 87% Save |
| Atorvastatin 20mg + Clopidogrel 75mg + Aspirin 75mg Capsules | 10's | ₹45.38 | ECOSPRIN, ATORVA, DEPLATT, AZTOGOLD | ₹111.23 | 59% Save |
| Clopidogrel 75mg + Aspirin 150mg Capsules | 15's | ₹58.13 | CLOPITAB | ₹127.51 | 54% Save |
| Rosuvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsules | 10's | ₹51.05 | ROSUVA, ROZAGOLD, ROSEDAY, ROSUMAC GOLD, CARDIOROSTIN | ₹189.05 | 73% Save |
| Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg Capsules | 10's | ₹56.72 | ROZAGOLD, ROSUVA, ROSEDAY, ROSUVASTIN, ROSUMAC GOLD | ₹317.47 | 82% Save |
| Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsules | 10's | ₹35.63 | DEPLATT, CLOPITAB | ₹87.70 | 59% Save |
| Clopidogrel 150mg Tablets | 10's | ₹33.75 | CLOPITAB, CLAVIX, DEPLATT, CLAVINTAS, CLOPILET | ₹162.42 | 79% Save |
| Rosuvastatin 20Mg + Clopidogrel 75Mg Capsules | 10's | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Clopidogrel generics.